tiprankstipranks
Papyrus Australia Ltd (AU:PPY)
ASX:PPY
Australian Market
Want to see AU:PPY full AI Analyst Report?

Papyrus Australia Ltd (PPY) AI Stock Analysis

1 Followers

Top Page

AU:PPY

Papyrus Australia Ltd

(Sydney:PPY)

Select Model
Select Model
Select Model
Neutral 43 (OpenAI - 5.2)
Rating:43Neutral
Price Target:
AU$0.01
â–²(40.00% Upside)
Action:ReiteratedDate:04/29/26
The score is primarily constrained by very weak financial performance (recurring losses, revenue disruption, ongoing cash burn, and higher leverage due to reduced equity). Technicals provide some offset via strong momentum above moving averages, but the extremely high RSI suggests an overheated move. Valuation is also pressured by a negative P/E tied to unprofitable operations.
Positive Factors
Low absolute debt
Modest nominal debt reduces near-term refinancing pressure and gives management limited financial flexibility to reorganize or pursue cost actions. With a small absolute debt burden, the company has some runway to stabilize operations even as equity is eroded, aiding survival over the next months if cash burn is controlled.
Negative Factors
Persistent unprofitable operations
Consistent negative EBIT and EBITDA show the core business is not generating operating profits. This ongoing unprofitability erodes equity and forces reliance on external funding, limiting strategic choices and increasing the probability of distress if losses continue over subsequent quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
Low absolute debt
Modest nominal debt reduces near-term refinancing pressure and gives management limited financial flexibility to reorganize or pursue cost actions. With a small absolute debt burden, the company has some runway to stabilize operations even as equity is eroded, aiding survival over the next months if cash burn is controlled.
Read all positive factors

Papyrus Australia Ltd (PPY) vs. iShares MSCI Australia ETF (EWA)

Papyrus Australia Ltd Business Overview & Revenue Model

Company Description
Papyrus Australia Limited develops a technology that converts the waste trunk of the banana palm into wood-based fibre products. Its products include fine ply sheets, veneered tabletops, liquid fertilizers, and food packaging products. The company...
How the Company Makes Money
null...

Papyrus Australia Ltd Financial Statement Overview

Summary
Income statement, balance sheet, and cash flow signals are very weak: recurring losses with negative EBIT/EBITDA, revenue volatility including a drop to zero in the latest annual period, and persistently negative operating/free cash flow. Balance-sheet risk increased as equity fell sharply and leverage rose (higher debt-to-equity), reducing financial resilience despite modest absolute debt.
Income Statement
8
Very Negative
Balance Sheet
24
Negative
Cash Flow
12
Very Negative
BreakdownTTMJun 2025Jun 2024Jun 2023Jun 2022Jun 2021
Income Statement
Total Revenue0.000.00672.96K0.000.00257.03K
Gross Profit-1.28K-1.85K672.96K96.28K-212.00164.31K
EBITDA-1.98M-2.17M-788.00K-1.14M-929.00K-517.00K
Net Income-2.60M-2.80M-644.00K-1.50M-1.18M-90.78K
Balance Sheet
Total Assets835.47K1.00M2.72M2.68M3.48M3.82M
Cash, Cash Equivalents and Short-Term Investments474.21K305.33K366.97K425.00K1.38M2.07M
Total Debt350.78K390.43K417.01K0.000.00150.22K
Total Liabilities863.19K666.83K584.89K201.79K203.99K121.92K
Stockholders Equity-27.72K337.71K2.14M2.48M3.27M3.70M
Cash Flow
Free Cash Flow-739.95K-543.12K-606.38K-1.24M-753.93K-498.38K
Operating Cash Flow-467.42K-430.85K-603.11K-1.24M-750.76K-498.38K
Investing Cash Flow-262.49K-112.27K-51.81K-413.74K-579.61K-1.06M
Financing Cash Flow925.59K481.28K596.89K700.00K635.00K3.60M

Papyrus Australia Ltd Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$18.38B12.79-2.54%3.03%1.52%-15.83%
50
Neutral
AU$130.45M21.823.40%2.84%-1.93%―
46
Neutral
AU$12.28M-2.32-11.24%――-64.86%
43
Neutral
AU$8.87M-1.61-1677.63%――-66.67%
43
Neutral
AU$7.44M-1.66-46.58%―12.64%-9.66%
43
Neutral
AU$11.13M-1.36-57.07%――49.56%
41
Neutral
AU$12.93M-2.801266.98%――29.92%
* Consumer Cyclical Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:PPY
Papyrus Australia Ltd
0.01
<0.01
40.00%
AU:CBY
Canterbury Resources Ltd.
0.05
0.02
125.00%
AU:TAT
R3D Resources Limited
0.02
-0.02
-47.50%
AU:SVY
Stavely Minerals Ltd
0.01
<0.01
18.18%
AU:LU7
Esports Mogul Limited
0.01
0.00
0.00%
AU:BRI
Big River Industries Ltd.
1.39
0.17
14.37%

Papyrus Australia Ltd Corporate Events

Papyrus Australia Options Lapse, Trimming Potential Future Equity
May 7, 2026
Papyrus Australia Ltd has disclosed a change to its capital structure, notifying the market that a tranche of 500,000 listed options, PPYAI, has ceased. The options, which carried various expiry dates and exercise prices, lapsed because the condit...
Papyrus Australia Confirms Compliance on 17.5 Million New Share Issue
Apr 29, 2026
Papyrus Australia Ltd has issued 17,500,000 fully paid ordinary shares without a prospectus under the Corporations Act, in line with prior ASX announcements and an Appendix 2A lodged on the same day. The company has confirmed its ongoing complianc...
Papyrus Australia Issues New Tranche of Unquoted Secured Convertible Notes
Apr 29, 2026
Papyrus Australia Ltd has notified the market of the issue of 263,846 new unquoted secured convertible notes, exercisable at $0.008 and expiring on 29 April 2028. The notes, which were previously flagged in an earlier capital raising document, are...
Papyrus Australia Issues 8.75 Million Unquoted Options Under Existing Transaction
Apr 29, 2026
Papyrus Australia Limited has announced the issue of 8,750,000 unquoted options with an exercise price of $0.02, expiring on April 29, 2028. The options, to be issued on April 29, 2026, form part of a previously announced transaction and are not i...
Papyrus Australia Seeks ASX Quotation for 17.5 Million New Shares
Apr 29, 2026
Papyrus Australia Ltd has applied to the Australian Securities Exchange for quotation of 17,500,000 new ordinary fully paid shares under its PPY ticker. The securities, issued on April 29, 2026, expand the company&#8217;s quoted capital base, pote...
Papyrus Australia advances R&D operations and moves closer to commercial production
Apr 28, 2026
Papyrus Australia reported strong operational progress for the March 2026 quarter, highlighted by the commissioning and early operation of its Adelaide Rapid Prototyping and RD facility. The site moved from installation to active production, enabl...
Papyrus Secures Vietnam Board Production Deal and Bolsters TBS Contract Delivery
Apr 28, 2026
Papyrus Australia has executed a binding board production contract with a Vietnam-based paperboard manufacturer, satisfying the first milestone under its supply agreement with TBS Mining Solutions. Under this arrangement, Papyrus will ship banana ...
Papyrus Australia Trading Reinstated on ASX After Capital Raising Update
Apr 23, 2026
Papyrus Australia Ltd has had the suspension of trading in its securities on the ASX lifted, allowing PPY shares to resume quotation. The reinstatement follows the company&#8217;s release of an announcement regarding a capital raising, signaling r...
Papyrus Australia Plans Convertible Note and Option-Funded Capital Raising
Apr 23, 2026
Papyrus Australia Limited has outlined a proposed capital raising through a placement involving unsecured convertible notes, options, and fully paid ordinary shares. The company plans to issue 264,279 unsecured convertible notes, 20,972,763 option...
Papyrus Australia Plans Share and Option Issue to Raise Capital
Apr 23, 2026
Papyrus Australia Ltd has notified the ASX of a proposed issue of securities via a placement or similar structure, scheduled for 15 July 2026. The proposal includes up to 26,973,465 fully paid ordinary shares and a total of 63,486,732 options with...
Papyrus Australia to Raise Capital via Secured Convertible Note Issue
Apr 23, 2026
Papyrus Australia has notified the ASX of a proposed issue of up to 800,000 secured convertible notes, each with an exercise price of $0.008 and a two-year term from the date of issue. The notes are to be issued via a placement or similar structur...
Papyrus Australia Plans July Placement of Shares and Options
Apr 23, 2026
Papyrus Australia has announced a proposed issue of new securities, comprising up to 15,000,000 ordinary fully paid shares and 7,500,000 options exercisable at $0.02 and expiring two years from the issue date. The placement is scheduled for 15 Jul...
Papyrus Australia Plans Capital Raise via New Share and Option Issue
Apr 23, 2026
Papyrus Australia Ltd has notified the ASX of a proposed placement or similar issue of new securities, comprising up to 17,500,000 fully paid ordinary shares and 8,750,000 options exercisable at $0.02 and expiring two years from their issue date. ...
Papyrus Australia to Tighten Disclosure After ASX Flags Loan Facility Breach
Apr 23, 2026
Papyrus Australia has disclosed that it failed to promptly inform the market about an extension to a $500,000 loan facility arranged with investors introduced by L39 Pty Ltd, after the Australian Securities Exchange determined this omission breach...
Papyrus Australia Reshapes Capital Structure With Placement and Convertible Notes
Apr 23, 2026
Papyrus Australia Ltd has launched a multi-pronged capital raising initiative involving a $175,000 share placement to sophisticated and professional investors at a small premium to its last traded price, accompanied by the issue of unlisted option...
Papyrus Australia Seeks ASX Trading Suspension Ahead of Capital Raising
Apr 22, 2026
Papyrus Australia Ltd has requested an immediate voluntary suspension of trading in its ordinary shares on the ASX, and the exchange has suspended the securities under Listing Rule 17.2. The halt is to manage continuous disclosure obligations whil...
Papyrus Australia Shares Halted Pending Capital Raising Announcement
Apr 19, 2026
Papyrus Australia has requested and been granted a trading halt in its securities on the ASX, effective 20 April 2026, pending the release of an announcement. Trading is expected to resume by the start of normal trading on 22 April 2026 or earlier...
Papyrus Australia Advances Commercialisation With Operational R&D Milestone
Mar 31, 2026
Papyrus Australia reported solid operational progress in February 2026 as it completed commissioning and moved into active operation at its Adelaide Rapid Prototyping and RD facility. The site is now running trials to optimise pulp blends, refine ...
Papyrus Australia Updates Registered Office Address
Mar 6, 2026
Papyrus Australia Ltd has changed its registered office and principal place of business, effective 5 March 2026, relocating to 2-3 Greenhill Road, Wayville, South Australia. The company emphasized that its existing contact details remain unchanged...
Papyrus Australia Advances Commercial Readiness With R&D Milestones and Funding
Feb 27, 2026
Papyrus Australia reported solid January progress in commissioning its Rapid Prototyping and RD facility in Adelaide and advancing its first Australian commercial production plant toward readiness. The company installed and optimised core prototyp...
Papyrus Australia Narrows Half-Year Loss but Balance Sheet Remains Thin
Feb 24, 2026
Papyrus Australia Limited reported a reduced half-year loss for the period ended 31 December 2025, with the loss after tax narrowing to $839,554 from $1,039,874 a year earlier. The company again did not declare or pay any dividends and its net tan...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Apr 29, 2026